Delivery Order SPE2DR25D2104-SPE2DR26F3PWW
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $6,359.77 by the Defense Logistics Agency for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors (0.5 mL). The contract was competitively awarded with firm fixed pricing and carries an ultimate completion date of December 9, 2025. The award was made without a set-aside designation, and performance is based in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate headquarters is located. This delivery order represents...
- AmerisourceBergen Drug Corp was awarded a delivery order on November 3, 2025, by the Defense Logistics Agency (DLA) for the supply of Mounjaro 7.5 mg/0.5 ml pen injections with a ceiling value of $3,363.28. This is a firm fixed-price delivery order with an ultimate completion date of November 4, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a non-competitive set-aside delivery against AmerisourceBergen Drug Corp's existing Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on October 30, 2025, for the supply of Mounjaro 15 mg/0.5 ml pen injections. The contract carries a ceiling value of $3,005.43 and utilizes firm fixed price pricing, with an ultimate completion date of October 31, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections, with a contract ceiling value of $1,597.14 and an ultimate completion date of September 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively under open competition. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 14, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections. The contract, valued at $20,199.71, is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025. This award was made on a competitive basis with no set-aside designation and represents a child contract under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,088.36 for Mounjaro 15 mg/0.5 mL pen injections on June 16, 2025, with an ultimate completion date of June 17, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), valued at approximately $1...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,448.81 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. This contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for ultimate completion by July 15, 2025, with performance taking place at the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,713.54 by the Defense Logistics Agency on October 23, 2025, for the supply of Mounjaro 12.5 mg/0.5 mL pen injections. The contract represents a firm fixed-price delivery order with an ultimate completion date of October 24, 2025, and was competitively awarded without set-aside designation. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency on May 7, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors valued at $27,363.70, with completion scheduled for May 8, 2025. The order represents a firm fixed-price, competitively awarded delivery against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. Performance will be...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 20, 2025, by the Defense Logistics Agency for the supply of Mounjaro 5 mg/0.5 ml pen injectors. This competitively awarded, non-set-aside contract carries a ceiling value of $1,543.85 and is structured as a firm fixed price delivery order with an ultimate completion date of October 21, 2025. The place of performance is AmerisourceBergen's...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3PWWDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on November 25, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections. This firm fixed-price delivery order, valued at $3,951.30, represents a non-set-aside, competitively awarded contract with an ultimate completion date of November 26, 2025. The award was executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive $999.99 billion prime vendor agreement running through December 2026 that enables the company to supply pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen's extensive federal contracting portfolio demonstrates its critical role in supporting Department of Defense medical procurement needs, with delivery orders encompassing a wide range of pharmaceutical products including specialty medications, vaccines, and medical devices across multiple therapeutic domains. The DLA Troop Support Medical contract vehicle provides the company with a flexible mechanism to fulfill ongoing medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This particular delivery order for Mounjaro, a diabetes medication, reflects the company's continued capacity to deliver specialty pharmaceutical products essential to military medical operations and veteran healthcare support.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 11/24/25 |